NasdaqCM - Nasdaq Real Time Price USD

Oncolytics Biotech Inc. (ONCY)

1.1700

-0.0700

(-5.65%)

At close: May 10 at 4:00 PM EDT

1.1600

-0.01

(-0.85%)

After hours: May 10 at 6:12 PM EDT

Key Events

Loading Chart for ONCY

9/21 12:03 PM

DELL

Previous Close 1.2400
Open 1.2400
Bid 1.1500 x 400
Ask 1.1800 x 200
Day's Range 1.1350 - 1.2500
52 Week Range 0.8800 - 3.3900
Volume 327,835
Avg. Volume 315,268
Market Cap (intraday) 88.241M
Beta (5Y Monthly) --
PE Ratio (TTM) --
EPS (TTM) -0.3000
Earnings Date May 9, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 4.84

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

www.oncolyticsbiotech.com

--

Full Time Employees

December 31

Fiscal Year Ends

Sector

Industry

Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is

S&P/TSX Composite index

.

YTD Return

ONCY

13.33%

S&P/TSX Composite index

6.44%

1-Year Return

ONCY

28.22%

S&P/TSX Composite index

8.37%

3-Year Return

ONCY

59.09%

S&P/TSX Composite index

14.57%

5-Year Return

ONCY

34.64%

S&P/TSX Composite index

36.68%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Oncolytics Biotech Inc.

1.1700

-5.65%

Mkt Cap 88.241M

Industry Biotechnology

Rigel Pharmaceuticals, Inc.

0.9844

-3.49%

Mkt Cap 172.67M

Industry Biotechnology

scPharmaceuticals Inc.

4.4800

-6.86%

Mkt Cap 161.524M

Industry Biotechnology

Sangamo Therapeutics, Inc.

0.5614

+7.26%

Mkt Cap 116.488M

Industry Biotechnology

Tempest Therapeutics, Inc.

3.2500

-6.34%

Mkt Cap 72.206M

Industry Biotechnology

1.2700

-1.55%

Mkt Cap 320.573M

Industry Biotechnology

IntelGenx Technologies Corp.

0.1590

-6.47%

Mkt Cap 27.771M

Industry Biotechnology

5.82

+2.92%

Mkt Cap 31.336M

Industry Biotechnology

Corvus Pharmaceuticals, Inc.

2.0800

+2.46%

Mkt Cap 130.107M

Industry Biotechnology

Revance Therapeutics, Inc.

3.3200

-22.61%

Mkt Cap 346.771M

Industry Biotechnology

Arrowhead Pharmaceuticals, Inc.

22.08

-10.68%

Mkt Cap 2.742B

Industry Biotechnology

Valuation Measures

As of 5/10/2024

Market Cap

87.67M
Enterprise Value

62.45M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

--
Price/Book (mrq)

4.40
Enterprise Value/Revenue

--
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-63.83%
Return on Equity (ttm)

-115.80%
Revenue (ttm)

--
Net Income Avi to Common (ttm)

-28.21M
Diluted EPS (ttm)

-0.3000

Balance Sheet and Cash Flow

Total Cash (mrq)

29.6M
Total Debt/Equity (mrq)

4.91%
Levered Free Cash Flow (ttm)

-17.46M

ONCY does not have Company Insights

XERS Xeris Biopharma Holdings, Inc.

1.7600

-6.38%

VTVT vTv Therapeutics Inc.

25.99

-3.13%

CYCC Cyclacel Pharmaceuticals, Inc.

2.2700

-1.73%

VBIV VBI Vaccines Inc.

0.6200

+2.77%

BLRX BioLineRx Ltd.

0.6520

-5.98%

AEMD Aethlon Medical, Inc.

1.1800

-2.48%

RIGL Rigel Pharmaceuticals, Inc.

0.9844

-3.49%

CRIS Curis, Inc.

15.72

-4.78%

AEZS Aeterna Zentaris Inc.

8.23

+3.13%

FBIO Fortress Biotech, Inc.

1.6700

-2.34%

GNPX Genprex, Inc.

2.3200

-4.92%

NNVC NanoViricides, Inc.

1.8900

+3.28%

LXRX Lexicon Pharmaceuticals, Inc.

1.7900

-5.29%

VSTM Verastem, Inc.

11.85

-0.59%

LPTX Leap Therapeutics, Inc.

2.7800

-4.47%

MBRX Moleculin Biotech, Inc.

4.7600

-1.65%